Status:
RECRUITING
Danish Vulva Cancer Recurrence Study
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Danish Cancer Society
Conditions:
Vulva Cancer
Vulva Neoplasm
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The overall aim is to investigate different aspects of recurrence detection in women with vulva cancer (VC) to identify optimal treatment- and surveillance programs. DaVulvaRec is a Danish nationwide...
Eligibility Criteria
Inclusion
- Primary or recurrent biopsy-verified squamous cell carcinoma of the vulva
- ≥ 18 years of age
- Able to understand oral and written information in Danish
Exclusion
- Active treatment for concurrent cancer and/or dissemination of concurrent cancer
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
1295 Patients enrolled
Trial Details
Trial ID
NCT06495554
Start Date
August 15 2024
End Date
December 31 2030
Last Update
November 15 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus N, Denmark, 8200
2
Copenhagen University Hospital
Copenhagen, Denmark, 2100